What is CVE-2026-50143?

CVE-2026-50143 is Actor MCP path authority injection leaks Apify token. The supplied enrichment data classifies it as SSRF mapped to CWE-918 Server-Side Request Forgery (SSRF).

Which versions are affected?

Affected product and version evidence is listed in the product table above. Current public advisories should be checked for exact version scope before patch targeting is finalized.

Is there active exploitation?

Exploitation is reported, but no independent confirmation is available in the sources we have. If exploitation is not confirmed from current sources, teams should document that status and continue monitoring KEV, vendor, and telemetry updates.

No. CVE-2026-50143 is not listed in CISA KEV in the supplied enrichment data. KEV status should be monitored because it can change after initial disclosure or after exploitation becomes publicly confirmed.

Is there a public exploit?

2 public PoC repositories reported; 1 marked weaponized in current dataset. Public exploit or PoC availability should raise triage priority, especially for exposed or business-critical systems.

How can defenders detect it?

Start with web/proxy/WAF logs, application logs, network IDS/IPS, cloud metadata access logs, egress proxy logs where available. Look for vulnerability-class behavior, product errors, suspicious authentication events, exploit probes, and abnormal process activity based only on evidence that applies to the affected product.

How should teams prioritize it?

Prioritize CVE-2026-50143 using CVSS 8.1, EPSS 0%, KEV status, public PoC status, and asset exposure. Internet-facing, privileged, or business-critical deployments should be handled first.

Are workarounds available?

Workarounds are not confirmed from current sources. Fixed-version evidence is listed in the mitigation section above.

Which threat actors are linked publicly?

No public threat actor linkage is confirmed from current sources. Do not attribute exploitation to a threat actor unless the source evidence explicitly supports that linkage.

What should be done in the next 24 hours?

Identify exposed assets running affected vendor/product/version combinations. Prioritize based on EPSS, PoC availability, and external exposure. Search available logs for exploit probes, errors, authentication anomalies, or suspicious child processes matching the vulnerability class. Open remediation tickets with affected assets, owners, evidence status, and detection coverage so decisions are traceable.

highSSRFpublic exploit

CVE-2026-50143

Actor MCP path authority injection leaks Apify token

The Apify MCP server enables AI agents to extract data from websites using ready-made scrapers, crawlers, and automation tools available on the Apify Store. Prior to 0.10.11, getActorMCPServerURL in src/mcp/actors.ts concatenates the trusted Actor standby URL with the attacker-controlled webServerMcpPath from an Actor definition without verifying the resulting origin, allowing a malicious Actor publisher to use a userinfo-style authority value to redirect connectMCPClient to a third-party host. The call-actor, fetch-actor-details, and actor-mcp tool-loading paths pass this URL to transports in src/mcp/client.ts that attach the victim Authorization bearer token, exposing the Apify API token and enabling access to Actors, stored data, and billable compute. A victim must invoke or inspect the attacker-controlled Actor. This issue is fixed in version 0.10.11.

Published Aug 18, 2026Updated Aug 18, 2026Sources: NVD, apify (CNA), GitHub, GitHub Security Advisory, SOCRadar CTI

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.

Exploitation

Reported

not confirmed by CISA

EPSS

ahead of 0% of scored CVEs

Affects

apify

2 products listed

CVSS base

8.1

high

Remediation

The vendor's own words where we have them.

Upgrade @apify/actors-mcp-server to 0.10.11 or later (npm advisory GHSA-6gr2-qh89-hxwm).

First 24 hours

Ordered from the record's own fields — exposure first, because you cannot patch what you have not found.

Identify exposed assets running affected vendor/product/version combinations.
Prioritize based on EPSS, PoC availability, and external exposure.
Search available logs for exploit probes, errors, authentication anomalies, or suspicious child processes matching the vulnerability class.

Affected scope

Vendor, product and version as the advisories word them.

Vendor	Product	Versions	Status
apify	apify-mcp-server	< 0.10.11	Vulnerable
npm	@apify/actors-mcp-server	< 0.10.11	Vulnerable

Attack characteristics

The CVSS vector, decoded. It describes the attack, not your exposure to it.

Availability

None

Confidentiality

High

Integrity

High

Scope

Unchanged

Attack Complexity

Low

Attack Vector

Network

Privileges Req

None

User Interaction

Required

Every base score collected

Sources score independently and disagree; each row says who scored it and under which version.

Score	Version	Severity	Expl.	Impact	Source
8.1	CVSS 3.1	high	2.8	5.2	GitHub (CNA), apify (CNA), GHSA

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N

What this weakness leads to

MITRE's own consequences and mitigations for the weakness class — the authority's wording, not guidance derived from the CVSS vector.

MITRE

CWE-918 · Server-Side Request Forgery (SSRF)

Read Application Data
Execute Unauthorized Code or Commands::

Weakness & attack patterns

CWE-918Server-Side Request Forgery (SSRF)

Inferred from the weakness class — not observed against this CVE.

CAPEC-664 · Server Side Request Forgery

Public exploit

Capability, not use: code existing is a different claim from anyone running it.

Repositories

1 of the 2 sampled are weaponized

Detection

Read off the CVSS vector and the weakness class. Starting points, not rules we have tested.

Search application, proxy, and WAF logs for requests touching /mcp/actors.ts, /mcp/client.ts.
Prioritize edge telemetry for network-reachable apify-mcp-server, @apify/actors-mcp-server.
Monitor for scanner or exploit-pattern traffic after 2 public PoC repositories were reported.

web/proxy/WAF logsapplication logsnetwork IDS/IPScloud metadata access logsegress proxy logs

Timeline

What happened to this CVE, newest first — with the readings a source repeats on a schedule counted underneath rather than listed.

2026
Added · CVSS 3.1 8.1 (AV:N)
Aug 18, 2026 · NVD
Initial · CVE published
Aug 18, 2026 · NVD
Added · GHSA-6gr2-qh89-hxwm published (high)
Jul 1, 2026 · GitHub Security Advisory

References

5 on the record

github.com/apify/apify-mcp-server/commit/ef686d77da3d3c86c30b2ae24218d756aa38e09c
Exploit, Third Party Advisory, Mitre
github.com/apify/apify-mcp-server/pull/927
Exploit, Third Party Advisory, Mitre
github.com/apify/apify-mcp-server/releases/tag/v0.10.11
Exploit, Third Party Advisory, Mitre
github.com/apify/apify-mcp-server/security/advisories/GHSA-6gr2-qh89-hxwm
Exploit, Third Party Advisory, Mitre
github.com/advisories/GHSA-6gr2-qh89-hxwm
Exploit, Third Party Advisory

Elsewhere on this site

apifyevery CVE for this vendor
npmevery CVE for this vendor
SSRFsame class
CWE-918other pages naming this weakness

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
No exploit packet captures, log samples, or incident case IDs supplied.

Answered from this record1

What should defenders know first?

CVE-2026-50143 is Actor MCP path authority injection leaks Apify token, a high vulnerability affecting apify-mcp-server, @apify/actors-mcp-server from apify, npm. The current evidence does not list it in CISA KEV, and the exploit status is: Exploitation is reported, but no independent confirmation is available in the sources we have. Public exploit evidence is: 2 public PoC repositories reported; 1 marked weaponized in current dataset. The affected-version evidence is listed in the key facts and affected products tables. Defenders should first verify whether exposed or business-critical assets run those versions, then apply vendor patches or mitigations, restrict reachable attack surface, and preserve logs for detection review. CVSS 8.1 describes technical severity, while EPSS 0% helps estimate near-term exploit likelihood; neither replaces asset context. Unknown fields should remain explicit in tickets, and threat actor, IOC, victimology, or payload claims should not be added unless a cited source supports them. Monitor CISA KEV, vendor advisories, NVD changes, public PoC repositories, and internal telemetry for update triggers.